$7.36
-2.5%Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Flat FCF growth. Stable but not expandingโmonitor for signs of business maturity or temporary headwinds.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
TDOC โข NYSE
| Teladoc Health, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||||||||
-200.3M | -1B | -220.4M | -13.7B | -428.8M | -485.1M | -98.9M | -97.1M | -106.8M | -74.2M | -58M | -17M | -6M | |
363.1M | 382.8M | 348.7M | 270.6M | 219.6M | 78.1M | 45M | 35.6M | 19.1M | 8.3M | 4.9M | 2.3M | 754K | |
-41.4M | -1.1M | -1.9M | -7.8M | 41.8M | -90.2M | -10.9M | -2.2M | -306K | 510K | 36K | 388K | 94K | |
80.4M | 146M | 201.6M | 0.0 | 0.0 | 475.5M | 66.7M | 43.8M | 30.6M | 7.7M | 3.1M | 533K | 298K | |
91.5M | 803.6M | 10.4M | 13.6B | 411.7M | 58.6M | 28.1M | 16.2M | 22.2M | 10.4M | 3.3M | 1.4M | 506K | |
(0.0) | (8.9M) | (7.2M) | (0.0) | (0.0) | (1.3M) | (1.3M) | (441K) | (137K) | (0.0) | (0.0) | (0.0) | (0.0) | |
1.1M | -36.3M | 11.6M | -61M | -50.3M | -90.5M | -156K | -1.1M | 720K | -4.5M | -427K | 1M | -1.7M | |
294.4M | 293.7M | 350M | 189.3M | 194M | -53.5M | 29.9M | -4.9M | -34.4M | -51.8M | -47.2M | -11.4M | -6.1M | |
INVESTING ACTIVITIES | |||||||||||||
-8.9M | -10.8M | -156.3M | -172.8M | -63.9M | -26M | -10.9M | -8.4M | -5.5M | -3.4M | -7.8M | -1.7M | -1.3M | |
-81.9M | (0.0) | (0.0) | (0.0) | -78.7M | -567.4M | -11.2M | -282.4M | -379.4M | -37M | -17.8M | -13.8M | -16.5M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -5M | -56.3M | -149.3M | -44.1M | -103M | (0.0) | (0.0) | |
740K | 0.0 | 0.0 | 2.5M | 60.9M | 2.5M | 52.1M | 84.2M | 85.8M | 110.7M | 20.4M | 0.0 | 0.0 | |
-175.9M | -113.3M | 1K | 2.5M | 8.7M | 0.0 | 39.7M | 5.5M | -66.4M | 65.3M | -84.2M | -665K | -1.1M | |
-266M | -124.1M | -156.3M | -167.7M | -73M | -591M | (25M) | -257.5M | -448.4M | (26.1M) | -108.2M | -15.6M | -17.8M | |
FINANCING ACTIVITIES | |||||||||||||
3.1M | 8.3M | 0.0 | 12.4M | 42.6M | 0.0 | 0.0 | 330.8M | 258.6M | 250K | 163.1M | -368K | -71K | |
-550.6M | 0.0 | 0.0 | -3.1M | -914K | 761.8M | 0.0 | 279.2M | 204M | 17.8M | 468K | 19.7M | 3M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -1.6M | (0.0) | (0.0) | (0.0) | (0.0) | -368K | -71K | |
-4.1M | -2K | 10.9M | -2.7M | -730K | 97.3M | 35.1M | 35.6M | 12.9M | 2.5M | 428K | 747K | 595K | |
-551.7M | 8.3M | 10.9M | 6.5M | 40.9M | 859.1M | 35.1M | 645.6M | 475.4M | 20.6M | 164M | 70.2M | 18.3M | |
CASH FLOW SUMMARY | |||||||||||||
6.1M | -3.3M | 965K | -3.3M | -1.8M | 4.3M | 388K | -2.1M | 191K | 0.0 | 0.0 | 0.0 | 0.0 | |
-517.2M | 174.7M | 205.5M | 24.7M | 160.2M | 219M | 90.4M | 381.2M | -7.2M | -5.1M | 8.6M | 43.2M | -5.5M | |
1.3B | 1.1B | 918.2M | 893.5M | 733.3M | 514.4M | 424M | 42.8M | 50M | 55.1M | 46.4M | 3.2M | 8.7M | |
781.1M | 1.3B | 1.1B | 918.2M | 893.5M | 733.3M | 514.4M | 424M | 42.8M | 50M | 55.1M | 46.4M | 3.2M | |
285.5M | 282.9M | 193.7M | 172.8M | 185.5M | -79.6M | 19M | -13.3M | -40M | -55.2M | -55M | -13.1M | -7.3M |
TDOC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 21, 2026 | May 21, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 29, 2026 | April 29, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 07, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 30, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 25, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 18, 2026 | February 18, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 12, 2026 | February 08, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 16, 2025 | December 11, 2025 | 2025 |
Continue your TDOC research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.